US2008214631A1PendingUtilityA1

Use of riluzole for the treatment of multiple sclerosis

52
Assignee: VERENIGING VOOR CHRISTELIJK WETENSCHAPPELIJK ONDERWIJSPriority: Jun 4, 1999Filed: Jan 24, 2008Published: Sep 4, 2008
Est. expiryJun 4, 2019(expired)· nominal 20-yr term from priority
Inventors:Chris Polman
A61P 25/00A61K 31/428
52
PatentIndex Score
0
Cited by
0
References
0
Claims

Abstract

Methods and compositions for the treatment of multiple sclerosis comprising riluzole (6-(trifluoromethoxy)-benzothiazolamine) are disclosed herein.

Claims

exact text as granted — not AI-modified
1 - 14 . (canceled) 
     
     
         15 . A pharmaceutical composition comprising:
 (a) a first composition comprising 6-(trifluoromethoxy)-2-benzothiazolamine or a salt thereof; and   (b) a second composition comprising a second agent selected from the group consisting of steroids, pain relievers, muscle relaxants, and immunosuppressants.   
     
     
         16 . The pharmaceutical composition of  claim 15 , wherein the second agent is a steroid. 
     
     
         17 . The pharmaceutical composition of  claim 15 , wherein the second agent is a pain reliever. 
     
     
         18 . The pharmaceutical composition of  claim 15 , wherein the second agent is a muscle relaxant. 
     
     
         19 . The pharmaceutical composition of  claim 15 , wherein the second agent is an immunosuppressant.

Join the waitlist — get patent alerts

Track US2008214631A1 — get alerts on status changes and closely related new filings.

We store only your email — no account needed. See our privacy policy.